Curran Daniel J. insider trades
Curran Daniel J. has filed 7 Form 4s with the SEC that we hold, for Xilio Therapeutics, Inc. (XLO) (Director), Alx Oncology Holdings INC (ALXO) (Director) and Catalyst Pharmaceuticals, INC. (CPRX) (Director). None of these filings reports a purchase (code P) or sale (code S) of common stock; they cover grants, option exercises and other codes. The first filing on our record is dated 2024-06-17 and the latest 2026-07-17.
Xilio Therapeutics, Inc. (XLO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Alx Oncology Holdings INC (ALXO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Catalyst Pharmaceuticals, INC. (CPRX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1887599) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms